{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:50:50Z","timestamp":1760151050780,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>This study aimed to evaluate the effect of androgen deprivation therapy (ADT) on retinal vascular occlusion (RVO) development in patients with prostate cancer, using data from Taiwan\u2019s National Health Insurance Research Database. A total of 1791, 1791, and 3582 patients were enrolled in the prostate cancer with ADT group, prostate cancer without ADT group, and the control group, respectively. The primary outcome was RVO occurrence, according to diagnostic codes. Cox proportional hazard regression was used to determine the adjusted hazard ratio (aHR) and 95% confidence interval (CI) of ADT and other covariates for RVO incidence. After a follow-up interval of up to 18 years, the patients with prostate cancer who received ADT showed significantly lower RVO incidence than the control group (aHR: 0.191, 95% CI: 0.059\u20130.621, p = 0.0059), after adjusting for multiple confounders. Hypertension was related to higher RVO incidence (aHR: 2.130, 95% CI: 1.127\u20134.027, p = 0.0199). Our overall results showed that using ADT for prostate cancer did not lead to a greater risk of RVO development. In fact, the patients with prostate cancer who received ADT had lower RVO incidence than those who did not receive ADT.<\/jats:p>","DOI":"10.3390\/ijerph19042268","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:25:45Z","timestamp":1645129545000},"page":"2268","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Androgen Deprivation Therapy for Prostate Cancer Did Not Increase the Risk of Retinal Vascular Occlusion: A Population-Based Cohort Study"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3938-4534","authenticated-orcid":false,"given":"Hsin-Le","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Taipei City Hospital, Renai Branch, Taipei 106243, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-0488","authenticated-orcid":false,"given":"Chia-Yi","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Nobel Eye Institute, Taipei 106074, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-9388","authenticated-orcid":false,"given":"Jing-Yang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402367, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Chen","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taipei City Hospital, Renai Branch, Taipei 106243, Taiwan"},{"name":"Department of Special Education, University of Taipei, Taipei 100234, Taiwan"},{"name":"Department of Optometry, University of Kang-Ning, Taipei 114311, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-7927","authenticated-orcid":false,"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402367, Taiwan"},{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 402367, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/annonc\/mds001","article-title":"Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer","volume":"23","author":"Bian","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","article-title":"Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity","volume":"61","author":"Higano","year":"2003","journal-title":"Urology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.urology.2017.11.055","article-title":"Association of Androgen Deprivation Therapy and Thromboembolic Events: A systematic review and metaanalysis","volume":"114","author":"Nead","year":"2018","journal-title":"Urology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bju.12967","article-title":"Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population","volume":"116","author":"Teoh","year":"2015","journal-title":"BJU Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jjco\/hyv025","article-title":"Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong","volume":"45","author":"Teoh","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1001\/jama.2011.1745","article-title":"Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A metaanalysis of randomized trials","volume":"306","author":"Nguyen","year":"2011","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.preteyeres.2004.12.001","article-title":"Prevalent misconceptions about acute retinal vascular occlusive disorders","volume":"24","author":"Hayreh","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archopht.126.5.692","article-title":"Retinal vein occlusion and traditional risk factors for atherosclerosis","volume":"126","author":"Wong","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/eye.2009.142","article-title":"Vascular risk factors for central retinal artery occlusion","volume":"24","author":"Rudkin","year":"2010","journal-title":"Eye (Lond.)"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0024-3205(02)01567-9","article-title":"Effects of testosterone and 17-beta-estradiol on TNF-alpha-induced E-selectin and VCAM-1 expression in endothelial cells. Analysis of the underlying receptor pathways","volume":"71","author":"Zhang","year":"2002","journal-title":"Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/en.2003-0789","article-title":"Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway","volume":"145","author":"Death","year":"2004","journal-title":"Endocrinology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-8993(88)90419-2","article-title":"In vitro steroid metabolism by rat retina","volume":"463","author":"Lanthier","year":"1988","journal-title":"Brain Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bjo.84.1.76","article-title":"Identification of androgen receptor protein and 5\u03b1-reductase mRNA in human ocular tissues","volume":"84","author":"Rocha","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40618-014-0118-1","article-title":"Effects of sex hormones on inflammatory response in male and female vascular endothelial cells","volume":"37","author":"Annibalini","year":"2014","journal-title":"J. Endocrinol. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/IAE.0000000000001869","article-title":"Testoserone supplementation and retinal vascular disease","volume":"38","author":"Dedania","year":"2018","journal-title":"Retina"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.eururo.2011.08.041","article-title":"Androgen deprivation therapy and the risk of stroke in patients with prostate cancer","volume":"60","author":"Azoulay","year":"2011","journal-title":"Eur. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1464-410X.2011.10459.x","article-title":"Hormone therapy for prostate cancer and the risk of stroke: A 5-year follow-up study","volume":"109","author":"Chung","year":"2012","journal-title":"BJU Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5489\/cuaj.3936","article-title":"Effects of androgen-deprivation therapy on hypercoagulability in prostate cancer patients: A prospective, longitudinal study","volume":"11","author":"Kaur","year":"2017","journal-title":"Can. Urol. Assoc. J."},{"doi-asserted-by":"crossref","unstructured":"Liao, K.M., Huang, Y.B., Chen, C.Y., and Kuo, C.C. (2019). Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan. BMC Cancer, 19.","key":"ref_22","DOI":"10.1186\/s12885-019-6487-2"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/4\/2268\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:21:19Z","timestamp":1760134879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/4\/2268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijerph19042268"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19042268","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}